June 12, 2019
San Diego, CA, June 12, 2019 – ACON Laboratories, Inc. announced today that it has been successful in obtaining an initial determination of non-infringement, as of June 4, 2019, from an administrative law judge (ALJ) of the U.S. International Trade Commission (ITC) in Investigation No. 337-TA-1116 regarding U.S. Patent No. 7,494,818. This particular patent is involved in an ongoing patent infringement dispute with PTS Diagnostics, a wholly owned subsidiary of Sinocare (Changsha, China). This dispute involves ACON Laboratories’ Mission,® Lipid Panel Monitoring System and PTS Diagnostics’ CardioChek® lipid analyzers. “While we have been successful and are pleased with the ALJ’s favorable ruling on the ‘818 patent, we will be petitioning the ITC regarding the other two patents involved in this case,” said Jinn-nan Lin, President and CTO of ACON Laboratories, headquartered in San Diego, California. About ACON Laboratories, Inc. ACON Laboratories Inc. is a privately owned Diagnostics and Medical Device company, which was founded in 1996, with its headquarters located in San Diego, California. ACON Laboratories, Inc. produces a broad range of medical diagnostic and healthcare products that are sold in over 130 countries worldwide. The company continues to expand its product lines through extensive research and development, with the goal of helping improve the health and well-being of patients around the world. ACON’s manufacturing facility is a US FDA registered manufacturer of rapid diagnostic and healthcare products.